Daniel is an entrepreneur, investor and advisor in the Life Science and Food industry.
He is co-founding three companies and was an Executive-in-Residence at TVM Capital Life Science in Munich for almost 4 years – amongst reviewing several hundred opportunities a year worldwide, closing a large pre-IPO investment with subsequent IPO, serving on the Board of Directors of three portfolio companies, and as part of new fund raising was instrumental for the first closing with a key European strategic investor.
He had joined TVM from Novartis, where he spent 12 years leading various line functions across three Divisions including Global Franchise Head Strategic Marketing for Immunology & Infectious Diseases, Pharma in Basel, Switzerland, Global Head of Development, Diagnostics for Vaccines & Diagnostics in Emeryville, CA, USA and Global Head New Product & Portfolio Strategy Biopharmaceuticals for Sandoz in Holzkirchen / Munich, Germany. He oversaw and was a team member for multiple collaborations, licensing deals and acquisitions from academic to multi-billion dollar transactions, world-wide commercial launches and FDA / EMA / CFDA / ANVISA registrations with respective global clinical trials.
Prior to Novartis he was at McKinsey & Company, Inc., was trained as an MD from Johannes-Gutenberg-University Mainz, Germany with clinical training in Germany, Switzerland and the USA (UC Davis Medical Center, Sacramento, CA) and was a scientific co-worker at the Institute for Occupational, Social and Environmental Medicine in Mainz for several years.